Annual report for Poly Medicure Ltd. for FY-2018
10-05-2018
Board to consider Dividend
Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 10, 2018, inter alia, to consider the following: 1. To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on March 31, 2018.2. To consider recommendation of Dividend, if any, on the Equity Shares for the financial year ended on March 31, 2018.02-05-2018
Board Meeting To Be Held On 10Th May, 2018
Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, the 10th May, 2018, inter alia to consider the following: a) To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on 31st March, 2018....02-05-2018
Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2018
Pursuant to the regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the certificate issued by practicing Company Secretary for the half year ended on 31st March, 2018. This is for your information and record.26-04-2018
Board Meeting-Closure of Trading Window
It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations and Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed from 26th April, 2018 to 12th May, 2018 (both days inclusive). This closure of the Trading Window has been occasioned by reason of the meeting of the Board of Directors of the Company, which is scheduled to be held on Thursday,...25-04-2018
Compliance Certificate For The Year Ended 31St March, 2018
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained by the Company's Registrar and Share Transfer Agent, viz., Mas Services Limited, which is a SEBI approved category-I, Registar & Transfer Agent, registered with Securities and Exchange Board...18-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Avinash ChandraDesignation :- Company Secretary and Compliance Officer18-04-2018
Shareholding for the Period Ended March 31, 2018
Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here17-04-2018
Announcement under Regulation 30 (LODR)-Updates
Subject: - Intimation of Commencement of Commercial Production Pursuant to Regulation 30(6) of the Listing Regulations, read with Para B of Part A of Schedule III, we hereby inform that the commercial production of our new plant situated at Plot No. 34, Sector 68, IMT Faridabad (Haryana) has commenced. Kindly take the above information on record.01-03-2018
Board Meeting-Outcome of Board Meeting
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 13th February, 2018, at Crowne Plaza Hotels, Community Center, Okhla Phase-I, New Delhi - 110020, approved the following businesses: a) Un-Audited Financial Results (Standalone) for the quarter and Nine Months ended on 31st December, 2017....13-02-2018